Medical personnel viewing the visitor of or in discussion



The findings of the research study allow for the formulation of the following conclusions:

  1. No uniform, standard approach is currently available regarding sexual function recovery in patients after radical prostatectomy for localized prostate cancer
  2. A combination of daily intake of PDE-5 inhibitors and the use of a vacuum extender makes it possible not only to prevent penis shortening, but also to increase its length by 0.75±0.01 cm;
  3. The rate of incidence of erectile dysfunction after radical prostatectomy was observed to be lower by 15 and 20% in the patients of groups I and II respectively compared to the control group;
  4. Erectile function significantly lowers the quality of life of postoperative patients.



1. Bosetti C., Bertuccio P., Chatenoud L. et al. Trends in mortality from urologic cancars in Europe, 1970-2008. Eur Urol 2011;60:1–15.
2. Analiz uronefrologičeskoj zabolevaemosti v Rossiskoj Federacii po dannym oficialnoj statistiki / Apolihin O.I., Sivkov A.V., Bešliev D.A., Solnzeva T.V., Komarova V.A.// Ėksperimentalnaâ i kliničeskaâ urologiâ. Nr. 2010.
3. Bill-Axelson A, Holmberg L, Filen F, et al; Scandinavian Prostate Cancer Group Study Number 4. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst 2008 aug; 100(16):1144–54.
4. Bianco FJ Jr, Scardino PT, Eastham JA. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function («trifecta»). Urology 2005 Nov;66(5Suppl):83–94.
5. EAU Guidelines on Prostate Cancer// 2014.
6. Salonia A. et al. Preservation and management of prostatectomy sexual dysfunction Part2: Recovery and preservation of erectile function, sexual desire, and orgasmic function. Eur Urol 2012; 62:273–86.
7. P.V. Glybočko, I.P. Matûhov, Û.G. Alâev, N.D. Ahvlediani, Ž.Š. Inoâtov „Seksual’naâ funkciâ pacientov, perenesših radikal’nujû prostaėktomiû: sovremennyj wzglâd na problemu”, Žurnal urologiâ Nr. 2, S. 112–116, Moskau 2015.
8. Maso E.B., Gamidov S.I., Ovčinnikov R.I., Iremašvili V.V. Novye aspekty patogeneza, profilaktiki i lečeniâ ėrektil’noj disfunkcii u bol’nyh posle radikal’noj prostatėktomii CONSILIUM MEDICUM, 2004 BAND 6 Nr. 7.
9. Puškar D.Û., Bormotin A.V., Govorov A.V. Lečenie ėrektilnoj disfunkcii u pacientov, perenesših radikal’nuû pozadilonnuû porostatėktomiû, s ispol’zovaniem ingibitorov fosfodiesterazy 5 tipa. Kačestvo žizni. Medicina.-2007.-5.- S. 36–41.
10. Roûk R.V. Optimisaciâ metodov diagnostiki i korrekcii osložnenij radikal’noj prostatėktomii na soiskanie učenoj stepeni kandidata medicinskih nauk. RUDN-2007.
11. Sitnikov N.V. Profilaktika osložnenij i rannââ reabilitaciâ bol’nyh posle radikal’noj prostatėktomii dissertaciâ na soiskanie učenoj stepeni doktora medicinskih nauk. FGU 3 CVKG 2008.
12. Veliev E.I., Vanin A.F., Kotov S.V., Šišlo V.K. Sovremennye aspekty patofisiologii i profilaktiki ėrektilnoj disfunkcii i kavernosnogo fibrosa posle radikal’noj prostatėktomii. Urologiâ.-2009.Nr. 2-S.46–51.
13. Kotov S.V. Profilaktika kavernoznogo fibroza polse nervosberegaûŝej radikalnoj prostatėktomii: dissertazija na soiskanie učenoj stepeni kandidata medicinskih nauk. RMAPO 2009. S. 105.
14. Ficarra V, Novara G, Galfano A, Stringari C, Baldassarre R, Cavalleri S et al. Twelve-month selfreported quality of life after retropubic radical prostatectomy: a prospective study with Rand 36-Item Health Survey (Short Form-36). BJU Int 2006; 97: 274.
15. Davison BJ, So AI, Goldenberg SL. Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer. BJU Int. 2007 Oct; 100(4):780-5. Epub 2007 Jun 19.
16. Rakul S.A., S.B. Petrow, M.D. Ivanova, N.N. Petrova Aprobaciâ „Universal’nogo oprosnika kačestva žizni bol’nyh rakom predstatel’noj železy“//Onkourologiâ: ežhekvartal’nyj naučno-praktičeskij žurnal.-2009.-Nr. 2.-S. 64–73.
17. Nâhin V.A. Funkcional’nye rezul’taty i kačestvo žizni pacientov posle radikal’noj pozadilonnoj prostatėktomii dissertaciâ na soiskanie učenoj stepeni kandidata medicinskih nauk. RMAPO 2007. S. 182.
18. Briganti A., Gallina A., Suardi N., Capitanio U., Tutolo M., Bianchi M., Passoni N., Salonia A., Colombo R., Di Girolamo V., Guazzoni G., Rigatti P., Montorsi P. Predicting erectile function recovery after bilateral nerve sparing radical prostatectomy: A proposal of a novel preoperative risk stratification. J Sex Med 2010; 7:2521–31.
19. McCullogh A. Penile change following radical prostatectomy: Size, smooth muscle atrophy and curve. Curr Urol Rep 2008; 9:492–9.
20. Gontero P., Galzerano M., Bartoletti R., Magnani C., Tizzani A., Frea B., Mondaini N. New insights into the pathogenesis of penile shortening after radical prostatectomy and the role of postoperative sexual function. J Urol 2007; 178:602–7.
21. Kohler TS, Pedro R., Hendlin K., Utz W., Ugarte R., Reddy P., Makhlouf A., Ryndin I., Canales BK., Weiland D., Nakib N., Ramani A., Anderson JK., Monga M.A. Pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int. 2007; 100:858–62.
22. Sexual Rehabilitation and Cancer Survivorship: A State of Art Review of Current Literature and Management Strategies in Male Sexual Dysfunction Among Prostate Cancer Survivors. J Sex Med 2013; 10 (suppl 1):102–111.
Penimaster Pro Studie
Penimaster Made in Germany
PeniMaster PRO for post-operative treatment of prostate cancer Clinical study 2015/2016
  • The combination of PDE5 inhibitors and PeniMaster PRO prevents penis shrinkage and enlarges the penis after prostate removal.
  • When untreated, erectile dysfunction occurs up to 20% more frequently after prostate removal.
  • Erectile dysfunction has a significant, negative impact on quality of life.
*** Health discount ***
The worldwide health crisis is also burdening consumers financially with increased health costs. In order to enable you to decide on one of our medical products today, we have temporarily reduced prices for selected products by up to 20 percent.